• Featured Product
  • KD/KO Validated

SLC35F2 Polyklonaler Antikörper

SLC35F2 Polyklonal Antikörper für WB,ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IP, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 25526-1-AP

Synonyme

HSNOV1, SLC35F2



Geprüfte Anwendungen

Erfolgreiche Detektion in WBA549-Zellen, Maushirngewebe

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:1000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

25526-1-AP bindet in WB, IP, ELISA SLC35F2 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen SLC35F2 fusion protein Ag20901
Vollständiger Name solute carrier family 35, member F2
Berechnetes Molekulargewicht 374 aa, 41 kDa
Beobachtetes Molekulargewicht 41-50 kDa
GenBank-ZugangsnummerBC039195
Gene symbol SLC35F2
Gene ID (NCBI) 54733
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SLC35F2, also named as Solute carrier family 35 member F2, is a 374 amino acid protein, which belongs to the SLC35F solute transporter family. SLC35F2 as a Multi-pass membrane protein is a putative solute transporter. SLC35F2 is highly homologous to the lung squamous cell cancer-related gene, LSCC3, which is highly expressed in lung squamous cell tumour tissues. However, the clinical implication of the SLC35F2 gene in tumour development and progression remains unclear.

Protokolle

Produktspezifische Protokolle
WB protocol for SLC35F2 antibody 25526-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Theranostics

USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2

Authors - Arun Pandian Chandrasekaran
humanWB

Mol Cancer Res

Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.

Authors - Michael D Nyquist
humanWB,IP

Biochem Biophys Res Commun

βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells

Authors - Jencia Carminha Colaco
humanWB

Onco Targets Ther

Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells.

Authors - Mei Chen
  • KD Validated
humanWB

Biochim Biophys Acta Gen Subj

E3 ubiquitin ligase APC/CCdh1 regulates SLC35F2 protein turnover and inhibits cancer progression in HeLa cells

Authors - Jencia Carminha Colaco